arXiv:2607. 15721v1 Announce Type: new Abstract: Cardiometabolic diseases remain among the most persistent drivers of preventable morbidity because diabetes, hypertension, and cardiovascular disease frequently co-occur and share metabolic, vascular, demographic, and behavioral determinants.
By S M Asif Hossain, Ruksat Khan Shayoni, M. F. Mridha, Jungpil Shin
arXiv:2606. 09860v1 Announce Type: cross Abstract: Non-alcoholic fatty liver disease (NAFLD) affects roughly 25% of global adults, posing substantial hepatic and cardiovascular risks.
By Xinze Zhang
arXiv:2605. 12895v2 Announce Type: replace-cross Abstract: Clinical decision-support systems are expert systems whose recommendations clinicians act on directly, yet they are usually cleared on one aggregate accuracy number from a held-out test set.
By Rohith Reddy Bellibatlu, Manpreet Singh, Yash Jajoo, Shyamal Lakhanpal, Abhishek Israni
arXiv:2607. 16253v1 Announce Type: cross Abstract: Machine learning-based Type 2 diabetes risk prediction models obtain good internal validation results but lose effectiveness in real-world applications due to deficient external testing and fairness assessment.
By Rajveer Singh Pall, Sameer Yadav, Siddharth Bhalerao, Sourabh Sahu, Ritu Ahluwalia, Bhaskar Awadhiya
arXiv:2606. 16056v1 Announce Type: new Abstract: Dysglycemia, encompassing both prediabetes and diabetes, affects huge numbers of adults worldwide, yet many of them remain undiagnosed.
By Black Sun, Chenyi Zhang, Kaiyi Ji, Xi Lu
arXiv:2607. 16934v1 Announce Type: cross Abstract: Traditional randomized trials often obscure clinically meaningful heterogeneity in treatment response by focusing on average effects.
By Xiaodi Li, Munhuwan Lee, Pengyang Li, Xiaoke Liu, Jose K. James, Patricia A. Pellikka, Cui Tao, Nansu Zong
arXiv:2607. 19524v1 Announce Type: cross Abstract: Federated learning (FL) offers a promising approach to privacy-preserving clinical risk prediction, but its deployment remains limited by restricted data sharing, client heterogeneity, class imbalance, and the lack of realistic tabular electronic health record (EHR) benchmarks.
By Akarsh K Nair, Muhammad Arifur Rahman, Nicholas Shopland, Andy Burton, Jun He, Yuan Shen, David Baldwin, Emma O'Dowd, Amna Burzic, Mufti Mahmud, David J. Brown
arXiv:2607. 26521v1 Announce Type: new Abstract: Conventional subgroup analyses can yield unstable and difficult-to-interpret conclusions, especially in observational biomedical data where each individual is observed under only one exposure state, true individual treatment effects are unavailable, and causal structure is uncertain.
By Vasundhara Acharya, Bulent Yener
arXiv:2510. 19893v2 Announce Type: replace Abstract: Medical AI systems demonstrated impressive diagnostic performance, yet they routinely show uneven accuracy across demographic groups, disadvantaging underrepresented populations.
By Shiqi Dai, Wei Dai, Jiaee Cheong, Paul Pu Liang
arXiv:2604. 16450v2 Announce Type: replace-cross Abstract: Intersectional biases in healthcare data can produce compound disparities in clinical machine learning models, yet most fairness evaluations assess demographic attributes independently.
By Nick Souligne, Vignesh Subbian
arXiv:2608. 01820v1 Announce Type: cross Abstract: Non-invasive blood glucose level (BGL) estimation from photoplethysmography (PPG) holds great promise for wearable health monitoring, but results across studies are hard to compare due to inconsistent datasets, data leakage, and non-standardized evaluation metrics.
By Supraja Ramesh, Markus Neufeld, Michael K\"uttner, Tobias R\"oddiger, Michael Beigl
arXiv:2602. 04266v2 Announce Type: replace-cross Abstract: Aortic valve disease (AVD) represents a major public health burden, while its diagnosis relies on echocardiography, which is limited by cost and specialist expertise, restricting scalable screening and risk stratification.
By Jiaze Wang, Qinghao Zhao, Zizheng Chen, Zhejun Sun, Deyun Zhang, Yuxi Zhou, Shenda Hong